DexCom (NASDAQ:DXCM – Get Free Report) had its target price increased by stock analysts at Canaccord Genuity Group from $89.00 to $99.00 in a research report issued to clients and investors on Monday, ...
Canaccord analyst William Plovanic raised the firm’s price target ... time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on DXCM ...
(NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced today that its latest innovation, the Dexcom G7 Continuous Glucose Monitoring ...
Investing.com -- DexCom Inc (NASDAQ:DXCM) shares up more than 2% following updated guidelines by the American Diabetes Association (ADA), which now recommend using continuous glucose monitors ...
Adults in the US who want to measure their blood glucose levels using a wearable sensor will soon be able to buy one over-the-counter (OTC) for the first time. The FDA has cleared Dexcom’s Stelo ...
We have not included all available products or offers. Learn more about how we make money and our editorial policies. If it feels like there’s a mystical force getting you to spend more time and money ...